Sergipe |
Nov./06 - Feb./07 |
G2P[4] – observed in 100% of the samples |
Gurgel et al.88. Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis. 2007;13:1571-3.
|
Sergipe |
Oct./06 - Apr./08 |
G2P[4] – observed in 95% of the samples |
Gurgel et al.3232. Gurgel RG, Bohland AK, Vieira SC, Oliveira DM, Fontes PB, Barros VF, et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology. 2009;137:1970-5.
|
Recife |
Mar./06 - May/07 |
G2 – observed in 100% of the samples |
Nakagomi et al.3333. Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol. 2008;153:591-3.
|
Rio de Janeiro |
2005 - 2007 |
G2P[4] – 1.4% (2005) / 44% (2006) / 96% (2007) |
Carvalho-Costa et al.3434. Carvalho-Costa FA, Araújo IT, Santos de Assis RM, Fialho AM, de Assis Martins CM, Bóia MN, et al. Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil. Emerg Infect Dis. 2009;15:95-7.
|
Parauapebas |
2006 - 2008 |
G2P[4] – observed in 90% of the samples |
Mascarenhas et al.3535. Mascarenhas JD, Lima CS, de Oliveira DS, Guerra SF, Maestri RP, Gabbay YB, et al. Identification of two sublineages of genotype G2 rotavirus among diarrheic children in Parauapebas, Southern Pará State, Brazil. J Med Virol. 2010;82:712-9.
|
São Paulo |
2006 - 2009 |
G9P[8] – dominant type in 2006 G2P[4] – dominant type in 2007 / 2008 / 2009 |
Cilli et al.1111. Cilli A, Luchs A, Morillo SG, Costa FF, Carmona RC, Timenetsky MC. Characterization of rotavirus and norovirus strains: a 6-year study (2004-2009). J Pediatr (Rio J). 2011;87:445-9.
|
São Paulo |
2006 - 2008 |
In hospitalized children: G2P[4] - 15% (2006) / 70% (2007) / 100% (2008) |
Sáfadi et al.3636. Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J. 2010;29:1019-22.
|
Belém |
2008 - 2009 |
In hospitalized children: G2P[4] predominance |
Justino et al.3737. Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, et al. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J. 2011;30:396-401.
|
Minas Gerais |
2009 - 2010 |
G2P[4] predominance |
Dulgheroff et al.3838. Dulgheroff AC, Figueiredo EF, Moreira LP, Moreira KC, Moura LM, Gouvêa VS, et al. Distribution of rotavirus genotypes after vaccine introduction in the Triângulo Mineiro region of Brazil: 4-Year follow-up study. J Clin Virol. 2012;55:67-71.
|
Curitiba |
2001 - 2008 |
In hospitalized patients: G2P[4] predominance after 2006 |
Pereira et al.3939. Pereira LA, Ferreira CE, Turchetto GD, Nogueira MB, Vidal LR, Cruz CR, et al. Molecular characterization of rotavirus genotypes in immunosuppressed and non-immunosuppressed pediatric patients. J Pediatr (Rio J). 2013;89:278-85.
|
18 Brazilian states |
2005 - 2009 |
G9 – dominant type in 2005 (52%) G2P[4] – 49% (2006) / 66% (2007) / 85% (2008) / 37%(2009) |
Carvalho-Costa et al.66. Carvalho-Costa FA, Volotão EM, de Assis RM, Fialho AM, de Andrade JS, Rocha LN, et al. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J. 2011;30 Suppl 1:S35-41.
|
Australia |
2007 - 2009 |
Increase in G2P[4] rates in most states where Rotarix® is in use |
Kirkwood et al.4040. Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J. 2011;30 Suppl 1:S48-53.
|